← Back to headlines
Investors Eye Market Opportunities Amid Growing GLP-1 Drug Demand
Financial analysts identify two publicly traded companies positioned to benefit from the rapid expansion of the GLP-1 receptor agonist market for weight loss and diabetes treatments.
25 Aug, 19:38 — 25 Aug, 19:38
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Novartis Pauses Autoimmune Cell Therapy Trials After Patient Deaths
2h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
12h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
15h ago